ISATUXIMAB

ISATUXIMAB was reported 5800 times

ISATUXIMAB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CRANIOCERVICAL SYNDROME 6 0.5000
1 SARS-COV-2 SEPSIS 14 0.3889
2 HAEMOPHILIA A WITH ANTI FACTOR VIII 3 0.3000
3 CHRONIC MYOCARDITIS 5 0.2632
4 PNEUMONIA PARAINFLUENZA VIRAL 3 0.2308
5 IVTH NERVE PARALYSIS 39 0.1646
6 STRESS ECHOCARDIOGRAM ABNORMAL 4 0.1538
7 BENCE JONES PROTEINURIA 6 0.1500
8 PARAINFLUENZAE VIRAL BRONCHITIS 2 0.1333
9 BRONCHITIS PNEUMOCOCCAL 2 0.0952
10 MILIARY PNEUMONIA 3 0.0938
11 PERIPORTAL SINUS DILATATION 5 0.0926
12 THERAPEUTIC AGENT-DIAGNOSTIC TEST INTERACTION 4 0.0870
13 MIDDLE EAR INFLAMMATION 8 0.0769
14 FACTOR VII DEFICIENCY 5 0.0746
15 PLASMA CELL MYELOMA REFRACTORY 86 0.0643
16 NEUROENDOCRINE TUMOUR OF THE LUNG METASTATIC 3 0.0556
17 COOMBS INDIRECT TEST POSITIVE 4 0.0541
18 STEM CELL THERAPY 3 0.0508
19 PARAINFLUENZA VIRUS INFECTION 5 0.0485
20 MALIGNANT SPINAL CORD COMPRESSION 2 0.0476
21 SPONDYLOLYSIS 8 0.0426
22 PNEUMONIA PARAINFLUENZAE VIRAL 6 0.0353
23 PLASMA CELL LEUKAEMIA 20 0.0333
24 FEBRILE INFECTION 32 0.0272
25 LARYNGEAL INFLAMMATION 5 0.0266
26 IGA NEPHROPATHY 44 0.0265
27 PNEUMOCOCCAL SEPSIS 17 0.0259
28 EAR, NOSE AND THROAT INFECTION 2 0.0244
29 ACTINOMYCOTIC PULMONARY INFECTION 2 0.0241
30 CORONAVIRUS PNEUMONIA 4 0.0240
31 MULTISYSTEM INFLAMMATORY SYNDROME 4 0.0231
32 CONJUNCTIVITIS VIRAL 6 0.0226
33 BRONCHOPNEUMOPATHY 8 0.0217
34 MONOCLONAL IMMUNOGLOBULIN INCREASED 6 0.0210
35 MENINGOCOCCAL BACTERAEMIA 2 0.0208
36 METAPNEUMOVIRUS PNEUMONIA 2 0.0208
37 EAR INFLAMMATION 6 0.0208
38 BONE MARROW INFILTRATION 8 0.0207
39 TRANSFUSION-RELATED CIRCULATORY OVERLOAD 5 0.0207
40 BLOOD STEM CELL HARVEST FAILURE 3 0.0203
41 BACTERIAL DIARRHOEA 4 0.0190
42 MENINGORADICULITIS 2 0.0185
43 FRACTURE PAIN 9 0.0167
44 PNEUMONIA RESPIRATORY SYNCYTIAL VIRAL 14 0.0166
45 HYPERTENSIVE URGENCY 9 0.0162
46 PNEUMOCOCCAL BACTERAEMIA 2 0.0159
47 ALVEOLAR LUNG DISEASE 3 0.0158
48 LIGHT CHAIN ANALYSIS INCREASED 16 0.0155
49 SEPTIC PULMONARY EMBOLISM 3 0.0154
50 CRYPTOCOCCAL MENINGOENCEPHALITIS 2 0.0153
51 MYOCARDIAL OEDEMA 6 0.0152
52 MALIGNANT FIBROUS HISTIOCYTOMA 2 0.0148
53 PLASMACYTOMA 27 0.0145
54 PERICARDITIS INFECTIVE 2 0.0144
55 PLATELET DYSFUNCTION 4 0.0144
56 MENINGITIS PNEUMOCOCCAL 5 0.0137
57 INFECTIOUS PLEURAL EFFUSION 19 0.0125
58 CARDIAC FAILURE HIGH OUTPUT 3 0.0124
59 DISEASE RISK FACTOR 5 0.0124
60 PNEUMONIA PNEUMOCOCCAL 18 0.0121
61 BLADDER OUTLET OBSTRUCTION 2 0.0121
62 SENSORIMOTOR DISORDER 6 0.0121
63 KERATOACANTHOMA 8 0.0117
64 ACUTE CARDIAC EVENT 2 0.0116
65 INFESTATION 3 0.0116
66 PANCREATIC ATROPHY 5 0.0114
67 BACTERIAL COLITIS 2 0.0111
68 ENDOMETRIAL ADENOCARCINOMA 7 0.0110
69 LISTERIOSIS 12 0.0108
70 RESPIRATORY TRACT INFECTION VIRAL 25 0.0107
71 HUMAN BOCAVIRUS INFECTION 2 0.0106
72 PLASMA CELL MYELOMA 408 0.0104
73 INFUSION RELATED HYPERSENSITIVITY REACTION 6 0.0100
74 RESTRICTIVE CARDIOMYOPATHY 3 0.0099
75 LOWER RESPIRATORY TRACT INFECTION VIRAL 5 0.0099
76 ATYPICAL HAEMOLYTIC URAEMIC SYNDROME 8 0.0098
77 PROTEIN DEFICIENCY 3 0.0096
78 LIGHT CHAIN ANALYSIS ABNORMAL 2 0.0096
79 HYPOPROTEINAEMIA 18 0.0095
80 ISCHAEMIC CEREBRAL INFARCTION 11 0.0095
81 HYPOGAMMAGLOBULINAEMIA 61 0.0093
82 OSTEOLYSIS 18 0.0088
83 SINUSITIS FUNGAL 7 0.0087
84 IMMUNE-MEDIATED PNEUMONITIS 2 0.0085
85 SJS-TEN OVERLAP 6 0.0085
86 PARAINFLUENZAE VIRUS INFECTION 13 0.0085
87 PULPITIS DENTAL 8 0.0085
88 MASTOCYTOSIS 4 0.0085
89 PNEUMONIA INFLUENZAL 10 0.0084
90 INFECTIVE ANEURYSM 4 0.0081
91 PRINZMETAL ANGINA 8 0.0080
92 MENINGITIS LISTERIA 4 0.0078
93 CEREBELLAR STROKE 3 0.0077
94 METAPNEUMOVIRUS INFECTION 6 0.0077
95 HERPES ZOSTER DISSEMINATED 6 0.0075
96 LIMB TRAUMATIC AMPUTATION 2 0.0074
97 INTERVERTEBRAL DISCITIS 14 0.0074
98 ENCEPHALOMYELITIS 2 0.0073
99 LABILE HYPERTENSION 2 0.0072
100 DIABETIC METABOLIC DECOMPENSATION 10 0.0072
101 THROMBOTIC MICROANGIOPATHY 70 0.0072
102 INTRAVASCULAR HAEMOLYSIS 4 0.0071
103 DEVICE RELATED THROMBOSIS 7 0.0071
104 PUNCTURE SITE HAEMORRHAGE 5 0.0071
105 CARDIO-RESPIRATORY DISTRESS 2 0.0070
106 ESCHERICHIA BACTERAEMIA 16 0.0068
107 COVID-19 PNEUMONIA 80 0.0068
108 CAMPYLOBACTER GASTROENTERITIS 4 0.0067
109 CONGESTIVE HEPATOPATHY 3 0.0067
110 SECONDARY IMMUNODEFICIENCY 8 0.0066
111 ENTEROCOLITIS VIRAL 2 0.0066
112 TRACHEITIS 5 0.0066
113 DEVICE RELATED BACTERAEMIA 2 0.0065
114 PARAPROTEINAEMIA 2 0.0065
115 FEBRILE BONE MARROW APLASIA 27 0.0063
116 HEPATITIS E 10 0.0063
117 SQUAMOUS CELL CARCINOMA OF SKIN 38 0.0063
118 HAEMOPERITONEUM 5 0.0062
119 PROSTATE INFECTION 6 0.0062
120 PNEUMONIA HAEMOPHILUS 3 0.0062
121 TINEA CRURIS 3 0.0060
122 POTENTIATING DRUG INTERACTION 20 0.0060
123 PNEUMONIA ESCHERICHIA 2 0.0059
124 PULMONARY NECROSIS 2 0.0059
125 IMMUNOGLOBULINS DECREASED 8 0.0058
126 BASAL GANGLIA INFARCTION 2 0.0058
127 NEUROENDOCRINE CARCINOMA 4 0.0058
128 HAEMOLYTIC URAEMIC SYNDROME 13 0.0056
129 DIVERTICULITIS INTESTINAL PERFORATED 2 0.0056
130 CORONARY ARTERY INSUFFICIENCY 2 0.0056
131 PLASMA CELL MYELOMA RECURRENT 18 0.0055
132 BRONCHOSTENOSIS 3 0.0055
133 ENTEROCOLITIS INFECTIOUS 5 0.0054
134 ENTEROBACTER SEPSIS 2 0.0054
135 CHOLANGIOCARCINOMA 8 0.0054
136 MECHANICAL ILEUS 3 0.0053
137 LYMPHOPENIA 74 0.0052
138 LABORATORY TEST INTERFERENCE 4 0.0051
139 RECTAL ADENOCARCINOMA 3 0.0050
140 BONE ABSCESS 2 0.0049
141 VENOUS THROMBOSIS LIMB 10 0.0048
142 PERITONEAL DIALYSIS 4 0.0048
143 SEPTIC EMBOLUS 4 0.0048
144 GASTROENTERITIS SALMONELLA 4 0.0048
145 TUMOUR LYSIS SYNDROME 42 0.0048
146 TOXIC ENCEPHALOPATHY 24 0.0047
147 INFLUENZA A VIRUS TEST POSITIVE 2 0.0046
148 HYPERFERRITINAEMIA 2 0.0046
149 CHONDROCALCINOSIS 3 0.0046
150 C-REACTIVE PROTEIN DECREASED 3 0.0046
151 PNEUMONIA STREPTOCOCCAL 5 0.0046
152 CHRONIC MYELOMONOCYTIC LEUKAEMIA 3 0.0045
153 PATHOLOGICAL FRACTURE 23 0.0045
154 SILENT MYOCARDIAL INFARCTION 3 0.0045
155 CYTOPENIA 53 0.0043
156 KLEBSIELLA BACTERAEMIA 4 0.0042
157 CYTOMEGALOVIRUS CHORIORETINITIS 8 0.0041
158 PNEUMONIA VIRAL 13 0.0041
159 HEPATITIS FULMINANT 12 0.0040
160 PARESIS 9 0.0040
161 INTRA-ABDOMINAL HAEMATOMA 5 0.0040
162 BACTERIAL SEPSIS 13 0.0040
163 INFUSION RELATED REACTION 260 0.0039
164 BONE LESION 14 0.0039
165 NEUTROPENIA 524 0.0038
166 SKIN NEOPLASM EXCISION 3 0.0038
167 OEDEMA MUCOSAL 4 0.0038
168 INAPPROPRIATE SCHEDULE OF PRODUCT DISCONTINUATION 2 0.0037
169 LEFT ATRIAL ENLARGEMENT 2 0.0037
170 MORNING SICKNESS 2 0.0037
171 PERIPHERAL MOTOR NEUROPATHY 5 0.0036
172 SALMONELLOSIS 6 0.0036
173 POLYNEUROPATHY 42 0.0035
174 CORONARY ARTERY DISSECTION 3 0.0035
175 CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY 5 0.0035
176 HAEMATOMA INFECTION 2 0.0035
177 PERIPHERAL SENSORY NEUROPATHY 20 0.0034
178 INTESTINAL PSEUDO-OBSTRUCTION 3 0.0034
179 BILIARY DILATATION 5 0.0034
180 CLOSTRIDIUM COLITIS 4 0.0033
181 GINGIVAL HYPERTROPHY 5 0.0033
182 PHARYNGEAL INFLAMMATION 4 0.0033
183 SOFT TISSUE INFECTION 6 0.0033
184 MALIGNANT MELANOMA IN SITU 4 0.0032
185 ARTHRITIS REACTIVE 2 0.0032
186 NASAL OBSTRUCTION 6 0.0032
187 CYTOMEGALOVIRUS INFECTION REACTIVATION 14 0.0032
188 KERATOPATHY 5 0.0032
189 NEUTROPENIC INFECTION 3 0.0031
190 OSTEOPOROTIC FRACTURE 6 0.0031
191 INFECTIVE EXACERBATION OF CHRONIC OBSTRUCTIVE AIRWAYS DISEASE 2 0.0031
192 CHORIORETINITIS 2 0.0031
193 LYMPHOCYTE COUNT INCREASED 10 0.0031
194 ATRIAL FLUTTER 24 0.0030
195 BRONCHITIS VIRAL 2 0.0030
196 THROMBOCYTOPENIA 330 0.0029
197 NEUTROPHIL COUNT DECREASED 120 0.0029
198 GASTRIC PERFORATION 8 0.0029
199 SIALOADENITIS 4 0.0029
200 TREATMENT DELAYED 5 0.0029
201 GRAVITATIONAL OEDEMA 2 0.0029
202 INTERVERTEBRAL DISC COMPRESSION 3 0.0029
203 LUNG CONSOLIDATION 8 0.0029
204 CYTOKINE RELEASE SYNDROME 56 0.0028
205 ORCHITIS 3 0.0028
206 BASAL CELL CARCINOMA 42 0.0027
207 RESPIRATORY TRACT INFECTION 70 0.0027
208 ATYPICAL PNEUMONIA 8 0.0027
209 HEPATIC CYTOLYSIS 34 0.0027
210 KLEBSIELLA SEPSIS 3 0.0027
211 FOLATE DEFICIENCY 3 0.0026
212 NEUROLOGICAL DECOMPENSATION 6 0.0026
213 PNEUMOCYSTIS JIROVECII PNEUMONIA 26 0.0026
214 SENSE OF OPPRESSION 3 0.0025
215 EXPOSURE VIA BODY FLUID 2 0.0025
216 BRONCHIAL CARCINOMA 2 0.0025
217 PNEUMONIA LEGIONELLA 4 0.0025
218 RESPIRATORY SYMPTOM 7 0.0025
219 BACTERAEMIA 29 0.0024
220 HYPERCALCAEMIA 30 0.0024
221 HYPERVOLAEMIA 12 0.0024
222 ADENOVIRUS INFECTION 7 0.0024
223 VACCINATION FAILURE 4 0.0024
224 HYPOCALCAEMIA 44 0.0023
225 LYMPHOCYTOSIS 5 0.0023
226 PROTEIN TOTAL ABNORMAL 3 0.0023
227 OESOPHAGEAL CANDIDIASIS 9 0.0023
228 INTESTINAL DILATATION 3 0.0022
229 FEBRILE NEUTROPENIA 149 0.0022
230 AORTIC VALVE STENOSIS 4 0.0022
231 HUMAN CHORIONIC GONADOTROPIN INCREASED 2 0.0022
232 HEPATITIS B REACTIVATION 7 0.0022
233 THERAPY PARTIAL RESPONDER 34 0.0022
234 ALPHA HAEMOLYTIC STREPTOCOCCAL INFECTION 2 0.0022
235 HYPERTENSIVE CRISIS 24 0.0022
236 PARKINSONISM 21 0.0022
237 SINUS PAIN 5 0.0021
238 ADENOCARCINOMA OF COLON 4 0.0021
239 PRERENAL FAILURE 3 0.0021
240 NEUTROPHIL COUNT ABNORMAL 6 0.0021
241 HAEMOLYTIC ANAEMIA 19 0.0021
242 ACUTE LYMPHOCYTIC LEUKAEMIA 6 0.0021
243 PNEUMONIA CRYPTOCOCCAL 2 0.0021
244 LEFT VENTRICULAR HYPERTROPHY 9 0.0021
245 MENINGITIS BACTERIAL 3 0.0021
246 DUODENAL ULCER HAEMORRHAGE 6 0.0021
247 COLON NEOPLASM 2 0.0021
248 MONOPLEGIA 9 0.0021
249 PULMONARY SEPSIS 3 0.0021
250 ACUTE ABDOMEN 3 0.0020
251 INFLAMMATORY MARKER INCREASED 10 0.0020
252 MESENTERIC VEIN THROMBOSIS 2 0.0020
253 ADMINISTRATION SITE EXTRAVASATION 2 0.0020
254 HAEMATOTOXICITY 19 0.0020
255 ACQUIRED HAEMOPHILIA 2 0.0020
256 THROMBOPHLEBITIS 7 0.0020
257 LUNG ADENOCARCINOMA 6 0.0020
258 PLATELET DISORDER 5 0.0020
259 JAUNDICE CHOLESTATIC 7 0.0020
260 PNEUMONIA BACTERIAL 18 0.0020
261 PALLIATIVE CARE 3 0.0020
262 ACUTE PULMONARY OEDEMA 11 0.0020
263 CONJUNCTIVAL OEDEMA 2 0.0019
264 SKIN TOXICITY 11 0.0019
265 BRAIN NATRIURETIC PEPTIDE INCREASED 6 0.0019
266 PHYSICAL DECONDITIONING 5 0.0019
267 METASTASES TO SKIN 2 0.0019
268 MYELODYSPLASTIC SYNDROME 28 0.0019
269 SKIN NECROSIS 10 0.0019
270 ONYCHOLYSIS 3 0.0019
271 METASTASES TO PLEURA 2 0.0019
272 COGWHEEL RIGIDITY 2 0.0019
273 ENTEROCOCCAL BACTERAEMIA 2 0.0019
274 GASTROINTESTINAL TOXICITY 9 0.0019
275 RHINITIS 15 0.0019
276 PULMONARY ARTERIAL PRESSURE INCREASED 3 0.0018
277 STREPTOCOCCAL INFECTION 10 0.0018
278 CARDIAC HYPERTROPHY 2 0.0018
279 GASTROENTERITIS 26 0.0018
280 COLITIS ISCHAEMIC 12 0.0018
281 CEREBELLAR INFARCTION 3 0.0018
282 PAPILLOEDEMA 8 0.0018
283 VASCULAR DEVICE INFECTION 8 0.0018
284 EPSTEIN-BARR VIRUS INFECTION 11 0.0018
285 FEMORAL NECK FRACTURE 9 0.0018
286 BLOOD FIBRINOGEN DECREASED 2 0.0018
287 ARTERIOSPASM CORONARY 7 0.0017
288 COVID-19 306 0.0017
289 CYTOMEGALOVIRUS COLITIS 4 0.0017
290 PYELONEPHRITIS 15 0.0017
291 STRESS CARDIOMYOPATHY 10 0.0017
292 PSEUDOMONAL SEPSIS 3 0.0017
293 ARTHRITIS BACTERIAL 7 0.0017
294 PULMONARY INFARCTION 4 0.0017
295 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 10 0.0017
296 HAEMOLYSIS 13 0.0017
297 PNEUMOCYSTIS JIROVECII INFECTION 2 0.0017
298 EMBOLISM ARTERIAL 2 0.0017
299 ENTEROCOCCAL INFECTION 8 0.0017
300 ESCHERICHIA URINARY TRACT INFECTION 7 0.0016
301 PNEUMONIA KLEBSIELLA 3 0.0016
302 PERIPHERAL SENSORIMOTOR NEUROPATHY 2 0.0016
303 INFECTED SKIN ULCER 3 0.0016
304 URINARY TRACT INFECTION BACTERIAL 4 0.0016
305 BONE MARROW TRANSPLANT 3 0.0016
306 PHLEBITIS 8 0.0016
307 ENDOCARDITIS 8 0.0016
308 INFUSION SITE IRRITATION 2 0.0016
309 BILIARY OBSTRUCTION 2 0.0015
310 DEVICE RELATED SEPSIS 3 0.0015
311 TOXIC SKIN ERUPTION 15 0.0015
312 ANAEMIA 284 0.0015
313 SUDDEN HEARING LOSS 3 0.0015
314 CLOSTRIDIAL INFECTION 5 0.0015
315 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 11 0.0015
316 HYPERURICAEMIA 6 0.0015
317 NEUTROPENIC COLITIS 3 0.0014
318 HYPERKERATOSIS 8 0.0014
319 HYPOPNOEA 5 0.0014
320 N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED 2 0.0014
321 LEUKOPENIA 71 0.0014
322 THROMBOTIC THROMBOCYTOPENIC PURPURA 5 0.0014
323 STAPHYLOCOCCAL SEPSIS 7 0.0014
324 ENTERITIS 9 0.0014
325 NEUTROPENIC SEPSIS 10 0.0014
326 NOROVIRUS INFECTION 2 0.0014
327 KLEBSIELLA INFECTION 7 0.0014
328 SQUAMOUS CELL CARCINOMA 13 0.0014
329 DYSPNOEA AT REST 4 0.0014
330 ESCHERICHIA SEPSIS 4 0.0014
331 CYTOMEGALOVIRUS VIRAEMIA 6 0.0013
332 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 11 0.0013
333 CHRONIC SINUSITIS 5 0.0013
334 HEPATITIS CHOLESTATIC 8 0.0013
335 MITRAL VALVE INCOMPETENCE 15 0.0013
336 CATHETER SITE INFECTION 5 0.0013
337 ATRIOVENTRICULAR BLOCK SECOND DEGREE 4 0.0013
338 METASTATIC MALIGNANT MELANOMA 3 0.0013
339 PNEUMONIA PSEUDOMONAL 2 0.0013
340 GINGIVITIS 7 0.0013
341 OPTIC ISCHAEMIC NEUROPATHY 5 0.0013
342 SPINAL PAIN 15 0.0013
343 VOLVULUS 3 0.0013
344 RESPIRATORY SYNCYTIAL VIRUS INFECTION 11 0.0013
345 TRICUSPID VALVE INCOMPETENCE 10 0.0013
346 AZOTAEMIA 5 0.0013
347 JC VIRUS INFECTION 2 0.0013
348 CUSHINGOID 4 0.0012
349 ACUTE LEUKAEMIA 2 0.0012
350 SLOW SPEECH 3 0.0012
351 CHOLECYSTITIS ACUTE 7 0.0012
352 BRONCHITIS CHRONIC 3 0.0012
353 RECURRENT CANCER 5 0.0012
354 DERMAL CYST 3 0.0012
355 BLOOD IMMUNOGLOBULIN G DECREASED 3 0.0012
356 PULMONARY EMBOLISM 115 0.0012
357 HYPERTRIGLYCERIDAEMIA 7 0.0012
358 SEPTIC SHOCK 52 0.0012
359 UROSEPSIS 11 0.0012
360 PNEUMONIA 386 0.0012
361 PLATELET COUNT DECREASED 127 0.0012
362 BRONCHOSPASM 17 0.0012
363 ENTEROBACTER INFECTION 2 0.0012
364 CARDIAC FAILURE 95 0.0012
365 HYPERPYREXIA 5 0.0012
366 HYPERTHERMIA 9 0.0012
367 DISEASE PROGRESSION 139 0.0012
368 FLANK PAIN 11 0.0012
369 CEREBRAL ISCHAEMIA 6 0.0012
370 AMYLOIDOSIS 2 0.0012
371 FAILURE TO THRIVE 6 0.0012
372 STAPHYLOCOCCAL BACTERAEMIA 5 0.0011
373 PANCYTOPENIA 64 0.0011
374 CYTOMEGALOVIRUS INFECTION 19 0.0011
375 SEPSIS 126 0.0011
376 HYPOKALAEMIA 52 0.0011
377 HEPATOTOXICITY 25 0.0011
378 OPHTHALMIC HERPES ZOSTER 2 0.0011
379 DERMATITIS BULLOUS 8 0.0011
380 PNEUMOPERITONEUM 2 0.0011
381 OPPORTUNISTIC INFECTION 2 0.0011
382 BRONCHITIS 80 0.0011
383 LEUKOENCEPHALOPATHY 4 0.0011
384 PRESYNCOPE 26 0.0011
385 PSYCHOMOTOR RETARDATION 3 0.0011
386 CARDIAC FAILURE ACUTE 7 0.0010
387 INFECTION 152 0.0010
388 PHARYNGITIS 13 0.0010
389 ARTERIAL DISORDER 2 0.0010
390 RETINAL VEIN OCCLUSION 3 0.0010
391 THYROID MASS 4 0.0010
392 ACUTE RESPIRATORY FAILURE 20 0.0010
393 GUILLAIN-BARRE SYNDROME 5 0.0010
394 BONE MARROW FAILURE 21 0.0010
395 MUCOSAL INFLAMMATION 27 0.0010
396 PNEUMONITIS 28 0.0010
397 RHINOVIRUS INFECTION 4 0.0010
398 SPINAL CORD COMPRESSION 4 0.0010
399 ACUTE KIDNEY INJURY 157 0.0010
400 PYELONEPHRITIS ACUTE 2 0.0010
401 VENOUS THROMBOSIS 4 0.0010
402 ERYSIPELAS 5 0.0010
403 CARDIAC DISCOMFORT 2 0.0010
404 EMBOLISM VENOUS 3 0.0010
405 KERATITIS 3 0.0010
406 DIASTOLIC DYSFUNCTION 3 0.0010
407 BENIGN PROSTATIC HYPERPLASIA 5 0.0010
408 PULMONARY HYPERTENSION 20 0.0010
409 TACHYPNOEA 13 0.0010
410 MULTIPLE ORGAN DYSFUNCTION SYNDROME 27 0.0010
411 ATRIAL TACHYCARDIA 2 0.0010
412 DELIRIUM 33 0.0009
413 SERUM FERRITIN INCREASED 5 0.0009
414 MENTAL STATUS CHANGES 26 0.0009
415 RADIATION PNEUMONITIS 2 0.0009
416 LIVER ABSCESS 3 0.0009
417 PERIODONTITIS 2 0.0009
418 MENINGITIS 6 0.0009
419 PULMONARY ARTERIAL HYPERTENSION 13 0.0009
420 GASTRIC POLYPS 2 0.0009
421 NEOPLASM RECURRENCE 3 0.0009
422 IMMUNE THROMBOCYTOPENIA 4 0.0009
423 TEMPERATURE INTOLERANCE 9 0.0009
424 APLASIA PURE RED CELL 3 0.0009
425 LEFT VENTRICULAR FAILURE 3 0.0009
426 RESPIRATORY DISTRESS 24 0.0009
427 EYELID DISORDER 2 0.0009
428 BLOOD CREATININE ABNORMAL 3 0.0009
429 DERMATITIS EXFOLIATIVE GENERALISED 3 0.0009
430 LOWER RESPIRATORY TRACT INFECTION 39 0.0009
431 PATELLA FRACTURE 2 0.0009
432 NEUROTOXICITY 15 0.0009
433 SPLENOMEGALY 10 0.0009
434 PYREXIA 295 0.0009
435 ATRIAL FIBRILLATION 83 0.0009
436 ARTERIOSCLEROSIS 8 0.0008
437 ACUTE CORONARY SYNDROME 7 0.0008
438 DEVICE RELATED INFECTION 13 0.0008
439 NEUROPATHY PERIPHERAL 80 0.0008
440 HUMERUS FRACTURE 4 0.0008
441 ATELECTASIS 8 0.0008
442 PANNICULITIS 2 0.0008
443 UPPER RESPIRATORY TRACT INFECTION 38 0.0008
444 CUTANEOUS VASCULITIS 3 0.0008
445 MALIGNANT MELANOMA 11 0.0008
446 DEVICE INFUSION ISSUE 2 0.0008
447 CARDIAC DYSFUNCTION 3 0.0008
448 GENERAL PHYSICAL HEALTH DETERIORATION 93 0.0008
449 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 4 0.0008
450 HAEMORRHAGE INTRACRANIAL 12 0.0008
451 TROPONIN INCREASED 6 0.0008
452 ACTINIC KERATOSIS 2 0.0008
453 HEPATITIS ACUTE 5 0.0008
454 HYPOXIA 27 0.0008
455 GASTROINTESTINAL INFLAMMATION 6 0.0008
456 ORAL CANDIDIASIS 10 0.0008
457 LUNG DISORDER 37 0.0008
458 ARTERIOSCLEROSIS CORONARY ARTERY 5 0.0008
459 BACTERIAL INFECTION 14 0.0007
460 APPENDICITIS 7 0.0007
461 COMPRESSION FRACTURE 4 0.0007
462 TACHYCARDIA 66 0.0007
463 PERIPHERAL ISCHAEMIA 3 0.0007
464 ISCHAEMIC STROKE 13 0.0007
465 ENCEPHALITIS 5 0.0007
466 EMBOLISM 6 0.0007
467 BONE PAIN 42 0.0007
468 HEMIPARESIS 12 0.0007
469 EJECTION FRACTION DECREASED 11 0.0007
470 FACIAL PARALYSIS 6 0.0007
471 PNEUMATOSIS INTESTINALIS 2 0.0007
472 NEUROLOGICAL SYMPTOM 4 0.0007
473 MYOCARDITIS 8 0.0007
474 ENTEROCOLITIS 4 0.0007
475 WHITE BLOOD CELL COUNT DECREASED 75 0.0007
476 ANAPHYLACTIC REACTION 38 0.0007
477 HYPOPHOSPHATAEMIA 5 0.0007
478 SKIN HAEMORRHAGE 10 0.0007
479 RASH MACULO-PAPULAR 15 0.0007
480 CHILLS 79 0.0007
481 ILEUS PARALYTIC 3 0.0007
482 MENINGITIS ASEPTIC 3 0.0007
483 METABOLIC ENCEPHALOPATHY 2 0.0007
484 HYPERCAPNIA 2 0.0007
485 INFLUENZA 74 0.0007
486 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 17 0.0007
487 PROSTATITIS 2 0.0007
488 BUNDLE BRANCH BLOCK RIGHT 3 0.0007
489 NEPHROGENIC ANAEMIA 3 0.0006
490 BRAIN DEATH 2 0.0006
491 DEEP VEIN THROMBOSIS 42 0.0006
492 ILEUS 8 0.0006
493 INFUSION SITE EXTRAVASATION 4 0.0006
494 PELVIC FRACTURE 5 0.0006
495 NON-CARDIAC CHEST PAIN 2 0.0006
496 TRANSAMINASES INCREASED 14 0.0006
497 ORTHOPNOEA 2 0.0006
498 DRUG ERUPTION 11 0.0006
499 HAEMATOMA 16 0.0006
500 ASPHYXIA 5 0.0006
501 PRODUCT PREPARATION ISSUE 4 0.0006
502 OSTEONECROSIS OF JAW 15 0.0006
503 SARS-COV-2 TEST POSITIVE 8 0.0006
504 OTITIS MEDIA 2 0.0006
505 CORONAVIRUS INFECTION 4 0.0006
506 ELECTROLYTE IMBALANCE 7 0.0006
507 SECOND PRIMARY MALIGNANCY 5 0.0006
508 TERMINAL STATE 4 0.0006
509 SUBARACHNOID HAEMORRHAGE 6 0.0006
510 RENAL FAILURE 78 0.0006
511 CACHEXIA 3 0.0006
512 PSEUDOMONAS INFECTION 5 0.0006
513 THERAPY NON-RESPONDER 26 0.0006
514 ACUTE MYELOID LEUKAEMIA 9 0.0006
515 LARGE INTESTINE POLYP 4 0.0006
516 TONSILLITIS 3 0.0006
517 BRONCHIOLITIS 2 0.0006
518 SUDDEN DEATH 6 0.0006
519 ACUTE RESPIRATORY DISTRESS SYNDROME 10 0.0006
520 HAEMORRHAGE SUBCUTANEOUS 2 0.0006
521 HEPATIC FUNCTION ABNORMAL 21 0.0006
522 CARDIO-RESPIRATORY ARREST 23 0.0005
523 VENTRICULAR TACHYCARDIA 9 0.0005
524 NERVOUS SYSTEM DISORDER 17 0.0005
525 ANAPHYLACTIC SHOCK 14 0.0005
526 HYPERTENSION 115 0.0005
527 ARTHROPOD BITE 4 0.0005
528 MALNUTRITION 6 0.0005
529 EPISTAXIS 40 0.0005
530 PANCREATITIS ACUTE 12 0.0005
531 CEREBRAL HAEMORRHAGE 19 0.0005
532 FRACTURE 10 0.0005
533 COLITIS 20 0.0005
534 CONJUNCTIVAL HAEMORRHAGE 2 0.0005
535 ANGINA PECTORIS 15 0.0005
536 CHEST DISCOMFORT 53 0.0005
537 METABOLIC DISORDER 3 0.0005
538 OXYGEN SATURATION DECREASED 29 0.0005
539 BRONCHOPULMONARY ASPERGILLOSIS 4 0.0005
540 PULMONARY OEDEMA 23 0.0005
541 PLEURAL EFFUSION 31 0.0005
542 PNEUMONIA FUNGAL 2 0.0005
543 RENAL IMPAIRMENT 42 0.0005
544 HEPATITIS B 3 0.0005
545 SENSORY LOSS 4 0.0005
546 APHASIA 15 0.0005
547 PLATELET COUNT ABNORMAL 3 0.0005
548 HYPERGLYCAEMIA 18 0.0005
549 SHOCK HAEMORRHAGIC 4 0.0005
550 DECUBITUS ULCER 4 0.0005
551 SUBDURAL HAEMATOMA 7 0.0005
552 HICCUPS 4 0.0005
553 LARYNGEAL OEDEMA 3 0.0005
554 CHOLANGITIS 3 0.0005
555 SPINAL COMPRESSION FRACTURE 4 0.0005
556 PETECHIAE 5 0.0005
557 DERMATITIS ALLERGIC 6 0.0005
558 INFUSION SITE SWELLING 3 0.0005
559 ONYCHOMADESIS 2 0.0005
560 INTERSTITIAL LUNG DISEASE 23 0.0005
561 INFUSION SITE ERYTHEMA 4 0.0005
562 CLOSTRIDIUM DIFFICILE COLITIS 5 0.0005
563 INCORRECT DRUG ADMINISTRATION RATE 2 0.0005
564 CARDIAC FAILURE CHRONIC 2 0.0005
565 DIVERTICULITIS 13 0.0005
566 METASTASES TO CENTRAL NERVOUS SYSTEM 6 0.0005
567 INCOHERENT 3 0.0005
568 COUGH 129 0.0005
569 OEDEMA PERIPHERAL 56 0.0005
570 ORTHOSTATIC HYPOTENSION 8 0.0005
571 EPILEPSY 14 0.0005
572 DYSGRAPHIA 3 0.0005
573 PARONYCHIA 2 0.0005
574 MUSCULOSKELETAL CHEST PAIN 7 0.0005
575 FEMUR FRACTURE 14 0.0005
576 DYSPNOEA EXERTIONAL 17 0.0005
577 ENCEPHALOPATHY 11 0.0004
578 LEFT VENTRICULAR DYSFUNCTION 3 0.0004
579 POSTOPERATIVE WOUND INFECTION 3 0.0004
580 AGEUSIA 11 0.0004
581 ACUTE MYOCARDIAL INFARCTION 13 0.0004
582 PNEUMONIA ASPIRATION 11 0.0004
583 RESPIRATORY FAILURE 32 0.0004
584 SKIN LESION 12 0.0004
585 DISEASE COMPLICATION 2 0.0004
586 JOINT EFFUSION 3 0.0004
587 LARGE INTESTINE PERFORATION 3 0.0004
588 CONJUNCTIVITIS 8 0.0004
589 ARTHRITIS INFECTIVE 2 0.0004
590 MALIGNANT NEOPLASM PROGRESSION 44 0.0004
591 PERFORMANCE STATUS DECREASED 2 0.0004
592 DIARRHOEA HAEMORRHAGIC 4 0.0004
593 TUBULOINTERSTITIAL NEPHRITIS 8 0.0004
594 STAPHYLOCOCCAL INFECTION 14 0.0004
595 HEPATOCELLULAR INJURY 6 0.0004
596 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 22 0.0004
597 CARDIAC TAMPONADE 2 0.0004
598 PROTEINURIA 8 0.0004
599 SYNCOPE 42 0.0004
600 CHOLECYSTITIS 5 0.0004
601 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 4 0.0004
602 CARDIOGENIC SHOCK 6 0.0004
603 NON-SMALL CELL LUNG CANCER 2 0.0004
604 MYELOSUPPRESSION 15 0.0004
605 HYPERCHOLESTEROLAEMIA 4 0.0004
606 SINUS BRADYCARDIA 4 0.0004
607 CEREBRAL INFARCTION 10 0.0004
608 MOUTH HAEMORRHAGE 3 0.0004
609 CONSTIPATION 89 0.0004
610 CARDIOMYOPATHY 6 0.0004
611 HOSPICE CARE 4 0.0004
612 GENERALISED OEDEMA 5 0.0004
613 HYPERAMMONAEMIA 2 0.0004
614 URINARY TRACT INFECTION 68 0.0004
615 HEPATIC FAILURE 12 0.0004
616 DRUG TOLERANCE 2 0.0004
617 LIPASE INCREASED 3 0.0004
618 SHOCK 9 0.0004
619 HEPATITIS 10 0.0004
620 VIRAL INFECTION 13 0.0004
621 DRUG RESISTANCE 10 0.0004
622 DIARRHOEA 251 0.0004
623 HYPOTENSION 78 0.0004
624 GASTROENTERITIS VIRAL 7 0.0004
625 APHTHOUS ULCER 3 0.0004
626 TRANSIENT ISCHAEMIC ATTACK 13 0.0004
627 POLYARTHRITIS 2 0.0004
628 STOMATITIS 23 0.0004
629 PANCREATITIS 20 0.0004
630 CELLULITIS 19 0.0004
631 SCIATICA 6 0.0004
632 EYE HAEMORRHAGE 5 0.0004
633 NIGHT SWEATS 12 0.0004
634 ANAL ABSCESS 2 0.0004
635 DYSPNOEA 210 0.0004
636 CATARACT 22 0.0004
637 ALTERED STATE OF CONSCIOUSNESS 8 0.0004
638 FAECALOMA 2 0.0004
639 BLOOD GLUCOSE FLUCTUATION 4 0.0004
640 INFLUENZA LIKE ILLNESS 30 0.0004
641 ELECTROCARDIOGRAM QT PROLONGED 13 0.0004
642 COAGULOPATHY 6 0.0004
643 EAR PAIN 7 0.0004
644 HYPOMAGNESAEMIA 5 0.0004
645 NASAL CONGESTION 21 0.0004
646 ANGIOPATHY 2 0.0004
647 UPPER GASTROINTESTINAL HAEMORRHAGE 6 0.0004
648 PULMONARY ALVEOLAR HAEMORRHAGE 2 0.0004
649 FACE OEDEMA 6 0.0004
650 DISSEMINATED INTRAVASCULAR COAGULATION 5 0.0004
651 REBOUND EFFECT 4 0.0004
652 MYOCARDIAL ISCHAEMIA 4 0.0004
653 INTENTIONAL DOSE OMISSION 10 0.0004
654 RECTAL HAEMORRHAGE 15 0.0003
655 HERPES VIRUS INFECTION 2 0.0003
656 MOUTH SWELLING 2 0.0003
657 PERICARDIAL EFFUSION 8 0.0003
658 BLINDNESS 14 0.0003
659 NAIL DISORDER 3 0.0003
660 RHINORRHOEA 22 0.0003
661 LUNG INFILTRATION 3 0.0003
662 LYMPHOCYTE COUNT DECREASED 6 0.0003
663 CARDIOTOXICITY 3 0.0003
664 PULMONARY MASS 5 0.0003
665 IMMUNODEFICIENCY 5 0.0003
666 GASTROINTESTINAL INFECTION 3 0.0003
667 BURSITIS 4 0.0003
668 INGUINAL HERNIA 2 0.0003
669 SKIN CANCER 7 0.0003
670 BRAIN FOG 5 0.0003
671 BLOOD LACTATE DEHYDROGENASE INCREASED 5 0.0003
672 FOREIGN BODY SENSATION IN EYES 2 0.0003
673 SUPRAVENTRICULAR TACHYCARDIA 3 0.0003
674 SKIN ULCER 8 0.0003
675 ANGINA UNSTABLE 2 0.0003
676 THERAPY CHANGE 3 0.0003
677 ASPERGILLUS INFECTION 2 0.0003
678 ADVERSE EVENT 28 0.0003
679 TOOTH INFECTION 4 0.0003
680 HYPOTHERMIA 3 0.0003
681 THROAT TIGHTNESS 8 0.0003
682 TASTE DISORDER 6 0.0003
683 ARRHYTHMIA 14 0.0003
684 OEDEMA 16 0.0003
685 PRODUCTIVE COUGH 14 0.0003
686 GINGIVAL BLEEDING 4 0.0003
687 PRODUCT PREPARATION ERROR 6 0.0003
688 NASOPHARYNGITIS 53 0.0003
689 EOSINOPHILIA 5 0.0003
690 HYPERKALAEMIA 10 0.0003
691 ASTHENIA 107 0.0003
692 COLD SWEAT 5 0.0003
693 BACK PAIN 65 0.0003
694 GRAFT VERSUS HOST DISEASE 2 0.0003
695 OFF LABEL USE 242 0.0003
696 CARDIOVASCULAR DISORDER 7 0.0003
697 PRODUCT PRESCRIBING ISSUE 6 0.0003
698 RESTLESS LEGS SYNDROME 5 0.0003
699 WOUND INFECTION 3 0.0003
700 THROMBOSIS 22 0.0003
701 DYSURIA 10 0.0003
702 URINARY RETENTION 9 0.0003
703 AGRANULOCYTOSIS 5 0.0003
704 COLON CANCER 4 0.0003
705 THROAT IRRITATION 12 0.0003
706 SKIN INFECTION 3 0.0003
707 NEPHROPATHY TOXIC 3 0.0003
708 INTESTINAL PERFORATION 3 0.0003
709 BREAST TENDERNESS 2 0.0003
710 HEPATOCELLULAR CARCINOMA 2 0.0003
711 HERPES ZOSTER 15 0.0003
712 GASTRIC HAEMORRHAGE 3 0.0003
713 WHITE BLOOD CELL COUNT INCREASED 10 0.0003
714 CHOLESTASIS 5 0.0003
715 EYELID OEDEMA 3 0.0003
716 RENAL DISORDER 12 0.0003
717 HYPOALBUMINAEMIA 2 0.0003
718 CYANOSIS 4 0.0003
719 ATAXIA 3 0.0003
720 NECK PAIN 14 0.0003
721 SENSORY DISTURBANCE 4 0.0002
722 LIVER DISORDER 11 0.0002
723 ADRENAL INSUFFICIENCY 3 0.0002
724 CHEST PAIN 45 0.0002
725 WEIGHT DECREASED 67 0.0002
726 DYSARTHRIA 9 0.0002
727 HAEMATOCHEZIA 13 0.0002
728 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 4 0.0002
729 LIVER FUNCTION TEST INCREASED 5 0.0002
730 INFUSION SITE PAIN 3 0.0002
731 ANURIA 2 0.0002
732 CARDIAC ARREST 19 0.0002
733 ALANINE AMINOTRANSFERASE INCREASED 14 0.0002
734 VOMITING 107 0.0002
735 PULMONARY CONGESTION 3 0.0002
736 IMMUNOSUPPRESSION 2 0.0002
737 ASPARTATE AMINOTRANSFERASE INCREASED 12 0.0002
738 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 16 0.0002
739 FACIAL PAIN 2 0.0002
740 PREGNANCY WITH CONTRACEPTIVE DEVICE 2 0.0002
741 GOUT 4 0.0002
742 OROPHARYNGEAL DISCOMFORT 2 0.0002
743 UVEITIS 3 0.0002
744 C-REACTIVE PROTEIN INCREASED 8 0.0002
745 WHEEZING 13 0.0002
746 NAUSEA 172 0.0002
747 FLUSHING 22 0.0002
748 DECREASED APPETITE 50 0.0002
749 MASS 3 0.0002
750 BLOOD CREATININE INCREASED 14 0.0002
751 HEPATIC ENCEPHALOPATHY 2 0.0002
752 NEPHROPATHY 2 0.0002
753 SINUS TACHYCARDIA 3 0.0002
754 DISEASE RECURRENCE 10 0.0002
755 PARALYSIS 3 0.0002
756 TYPE 2 DIABETES MELLITUS 7 0.0002
757 PANCREATIC CARCINOMA 6 0.0002
758 BLOOD PRESSURE INCREASED 31 0.0002
759 NEOPLASM PROGRESSION 7 0.0002
760 HYPERSENSITIVITY 37 0.0002
761 FULL BLOOD COUNT DECREASED 4 0.0002
762 CORONARY ARTERY DISEASE 6 0.0002
763 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 2 0.0002
764 LUNG NEOPLASM MALIGNANT 8 0.0002
765 RIB FRACTURE 4 0.0002
766 INTENTIONAL PRODUCT USE ISSUE 17 0.0002
767 TREATMENT FAILURE 16 0.0002
768 COGNITIVE DISORDER 9 0.0002
769 DEAFNESS 5 0.0002
770 MUSCLE SPASMS 35 0.0002
771 RASH 83 0.0002
772 GASTRITIS 5 0.0002
773 ERYTHEMA 39 0.0002
774 FATIGUE 147 0.0002
775 OSTEOARTHRITIS 8 0.0002
776 ULCER 3 0.0002
777 ABSCESS 3 0.0002
778 JAUNDICE 5 0.0002
779 DISTURBANCE IN ATTENTION 10 0.0002
780 DEATH 159 0.0002
781 INTERVERTEBRAL DISC PROTRUSION 4 0.0002
782 TREATMENT NONCOMPLIANCE 10 0.0002
783 GASTROINTESTINAL PAIN 2 0.0002
784 GAMMA-GLUTAMYLTRANSFERASE INCREASED 4 0.0002
785 STEVENS-JOHNSON SYNDROME 4 0.0002
786 HYPONATRAEMIA 10 0.0002
787 PAIN IN JAW 5 0.0002
788 MUSCULOSKELETAL DISCOMFORT 3 0.0002
789 PARANOIA 3 0.0002
790 NEOPLASM 2 0.0002
791 METASTASES TO LUNG 2 0.0002
792 DIABETES MELLITUS INADEQUATE CONTROL 3 0.0002
793 BLOOD IRON DECREASED 2 0.0002
794 POLLAKIURIA 7 0.0002
795 DIABETIC KETOACIDOSIS 4 0.0002
796 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 30 0.0002
797 HEPATIC CANCER 4 0.0002
798 LEUKOCYTOSIS 3 0.0002
799 OSTEOMYELITIS 3 0.0002
800 BLOOD PRESSURE DECREASED 11 0.0002
801 THERAPEUTIC RESPONSE DECREASED 10 0.0002
802 GLOMERULAR FILTRATION RATE DECREASED 2 0.0002
803 TREMOR 27 0.0002
804 INJECTION SITE EXTRAVASATION 2 0.0002
805 EXTRAPYRAMIDAL DISORDER 4 0.0002
806 CARDIAC DISORDER 15 0.0002
807 PEMPHIGUS 2 0.0002
808 INTESTINAL OBSTRUCTION 6 0.0002
809 FOOT FRACTURE 3 0.0002
810 HEAD INJURY 5 0.0002
811 HAEMATEMESIS 4 0.0002
812 CYSTITIS 5 0.0002
813 HAEMOGLOBIN DECREASED 16 0.0002
814 DYSPHONIA 9 0.0002
815 ORAL HERPES 3 0.0002
816 CEREBROVASCULAR ACCIDENT 26 0.0002
817 PARAESTHESIA 24 0.0002
818 HEART RATE INCREASED 15 0.0002
819 VISUAL ACUITY REDUCED 5 0.0002
820 ABDOMINAL PAIN 35 0.0002
821 JOINT RANGE OF MOTION DECREASED 2 0.0001
822 DYSGEUSIA 11 0.0001
823 HEPATIC ENZYME INCREASED 10 0.0001
824 SINUSITIS 15 0.0001
825 ILLNESS 15 0.0001
826 PERITONITIS 3 0.0001
827 CHRONIC KIDNEY DISEASE 11 0.0001
828 HUNGER 2 0.0001
829 DEMENTIA 4 0.0001
830 INSOMNIA 38 0.0001
831 BLOOD TEST ABNORMAL 2 0.0001
832 FALL 47 0.0001
833 OROPHARYNGEAL PAIN 13 0.0001
834 MELAENA 3 0.0001
835 INFLAMMATION 7 0.0001
836 DRUG EFFECT LESS THAN EXPECTED 2 0.0001
837 NEOPLASM MALIGNANT 9 0.0001
838 ORAL PAIN 3 0.0001
839 SNEEZING 3 0.0001
840 ADVERSE DRUG REACTION 12 0.0001
841 HYPOAESTHESIA ORAL 2 0.0001
842 CONFUSIONAL STATE 21 0.0001
843 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 7 0.0001
844 DRUG-INDUCED LIVER INJURY 4 0.0001
845 DYSPHAGIA 12 0.0001
846 DEPRESSED LEVEL OF CONSCIOUSNESS 5 0.0001
847 PRODUCT PRESCRIBING ERROR 3 0.0001
848 CARDIAC FAILURE CONGESTIVE 10 0.0001
849 PROSTATE CANCER 10 0.0001
850 HYPERHIDROSIS 16 0.0001
851 EYE PAIN 7 0.0001
852 MENTAL IMPAIRMENT 3 0.0001
853 HOSPITALISATION 19 0.0001
854 DRUG INEFFECTIVE 162 0.0001
855 OSTEONECROSIS 4 0.0001
856 CONDITION AGGRAVATED 37 0.0001
857 GENERALISED TONIC-CLONIC SEIZURE 2 0.0001
858 WEIGHT INCREASED 27 0.0001
859 PSYCHOMOTOR HYPERACTIVITY 2 0.0001
860 DRY EYE 6 0.0001
861 GAIT DISTURBANCE 23 0.0001
862 SKIN DISORDER 4 0.0001
863 GASTROINTESTINAL HAEMORRHAGE 10 0.0001
864 PERICARDITIS 2 0.0001
865 PAIN 73 0.0001
866 CANDIDA INFECTION 2 0.0001
867 GASTRIC CANCER 3 0.0001
868 HYPOPHAGIA 3 0.0001
869 THERAPY CESSATION 6 0.0001
870 PERIPHERAL SWELLING 18 0.0001
871 DIPLOPIA 3 0.0001
872 SPEECH DISORDER 6 0.0001
873 HEART RATE DECREASED 4 0.0001
874 METASTASES TO LIVER 2 0.0001
875 HYPOAESTHESIA 17 0.0001
876 BRADYCARDIA 6 0.0001
877 LYMPHADENOPATHY 4 0.0001
878 EAR INFECTION 3 0.0001
879 BREAST CANCER FEMALE 3 0.0001
880 RASH PRURITIC 6 0.0001
881 VISION BLURRED 15 0.0001
882 NEPHROLITHIASIS 5 0.0001
883 ARTHRALGIA 45 0.0001
884 HAEMOPTYSIS 3 0.0001
885 HEPATIC STEATOSIS 2 0.0001
886 HEADACHE 66 0.0001
887 GASTRIC ULCER 2 0.0001
888 PAIN IN EXTREMITY 31 0.0001
889 MALAISE 46 0.0001
890 HYPERSOMNIA 3 0.0001
891 ERUCTATION 2 0.0001
892 BLOOD PRESSURE SYSTOLIC INCREASED 2 0.0001
893 HAEMORRHOIDS 2 0.0001
894 KIDNEY INFECTION 2 0.0001
895 INJECTION SITE REACTION 7 0.0001
896 ARTHRITIS 8 0.0001
897 LABORATORY TEST ABNORMAL 3 0.0001
898 DYSPEPSIA 10 0.0001
899 URINARY INCONTINENCE 3 0.0001
900 GASTROINTESTINAL DISORDER 9 0.0001
901 RESPIRATORY DISORDER 3 0.0001
902 MYALGIA 17 0.0001
903 SOMNOLENCE 20 0.0001
904 PRODUCT ADMINISTRATION ERROR 2 0.0001
905 DIZZINESS 49 0.0001
906 THERAPY INTERRUPTED 7 0.0001
907 LIMB DISCOMFORT 3 0.0001
908 MUSCULAR WEAKNESS 11 0.0001
909 PRURITUS 37 0.0001
910 DERMATITIS 2 0.0001
911 MOUTH ULCERATION 2 0.0001
912 PALPITATIONS 11 0.0001
913 METABOLIC ACIDOSIS 3 0.0001
914 HYPOACUSIS 4 0.0001
915 POOR QUALITY SLEEP 2 0.0001
916 CLOSTRIDIUM DIFFICILE INFECTION 2 0.0001
917 EYE PRURITUS 3 0.0001
918 ASTHMA 10 0.0001
919 NO ADVERSE EVENT 16 0.0001
920 HAEMATURIA 3 0.0001
921 ABDOMINAL PAIN UPPER 18 0.0001
922 MEMORY IMPAIRMENT 12 0.0001
923 MUSCLE TWITCHING 2 0.0001
924 DRY MOUTH 7 0.0001
925 ABDOMINAL DISTENSION 9 0.0001
926 PRODUCT USE ISSUE 16 0.0001
927 SLEEP DISORDER 6 0.0001
928 PRODUCT USE IN UNAPPROVED INDICATION 21 0.0001
929 RASH ERYTHEMATOUS 4 0.0001
930 URTICARIA 14 0.0001
931 MOBILITY DECREASED 6 0.0001
932 CONTUSION 8 0.0001
933 DEHYDRATION 11 0.0001
934 NEURALGIA 2 0.0001
935 DISCOMFORT 5 0.0001
936 AGITATION 6 0.0001
937 LIVER INJURY 2 0.0001
938 EYE SWELLING 3 0.0001
939 DIABETES MELLITUS 6 0.0001
940 FLUID RETENTION 4 0.0001
941 PRODUCT DOSE OMISSION ISSUE 23 0.0001
942 LOSS OF CONSCIOUSNESS 10 0.0001
943 ERECTILE DYSFUNCTION 2 0.0001
944 EXPOSURE VIA SKIN CONTACT 2 0.0001
945 HAEMORRHAGE 8 0.0001
946 MYOCARDIAL INFARCTION 13 0.0001
947 BLOOD BILIRUBIN INCREASED 2 0.0001
948 PALLOR 2 0.0001
949 VISUAL IMPAIRMENT 9 0.0001
950 FEELING COLD 2 0.0001
951 SKIN EXFOLIATION 6 0.0001
952 MENTAL DISORDER 3 0.0001
953 BLADDER CANCER 4 0.0001
954 ANXIETY 19 0.0001
955 JOINT SWELLING 8 0.0001
956 LACRIMATION INCREASED 2 0.0001
957 TOXICITY TO VARIOUS AGENTS 11 0.0001
958 DRUG INTERACTION 10 0.0001
959 COLORECTAL CANCER 3 0.0001
960 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 3 0.0001
961 HIP FRACTURE 2 0.0001
962 DRUG INTOLERANCE 6 0.0001
963 SWELLING FACE 4 0.0001
964 INCORRECT DOSE ADMINISTERED 14 0.0001
965 SEIZURE 7 0.0001
966 FUNGAL INFECTION 2 0.0001
967 NERVOUSNESS 3 0.0001
968 ECZEMA 3 0.0001
969 DEPRESSION 13 0.0001
970 PRODUCT STORAGE ERROR 5 0.0001
971 INJURY 4 0.0001
972 BLISTER 3 0.0001
973 UNEVALUABLE EVENT 4 0.0001
974 GASTROOESOPHAGEAL REFLUX DISEASE 4 0.0000
975 VERTIGO 3 0.0000
976 FEELING HOT 3 0.0000
977 ABDOMINAL DISCOMFORT 8 0.0000
978 BALANCE DISORDER 4 0.0000
979 BLOOD GLUCOSE INCREASED 8 0.0000
980 OCULAR HYPERAEMIA 2 0.0000
981 DEPRESSED MOOD 2 0.0000
982 ALOPECIA 7 0.0000
983 LETHARGY 2 0.0000
984 EYE IRRITATION 2 0.0000
985 SUICIDAL IDEATION 3 0.0000
986 INJECTION SITE ERYTHEMA 4 0.0000
987 DRY SKIN 4 0.0000
988 FEELING ABNORMAL 7 0.0000
989 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 3 0.0000
990 OVERDOSE 3 0.0000